Curasight and Curium announce global partnership for uTRACE[®] in prostate cancer
Curasight to develop its proprietary uTRACE® PET imaging technology to obtain regulatory approval in EU and USA, with Curium responsible for manufacturing and commercialization Curasight eligible for up to USD 70 mn in d…
Taggar
Personer